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ARTICLE
A cancer rainbow mouse for visualizing the
functional genomics of oncogenic clonal expansion
Peter G. Boone1,2,9,10, Lauren K. Rochelle1,2,9,10, Joshua D. Ginzel2, Veronica Lubkov1,2, Wendy L. Roberts2,
P.J. Nicholls2, Cheryl Bock3, Mei Lang Flowers3, Richard J. von Furstenberg4, Barry R. Stripp5, Pankaj Agarwal1,
Alexander D. Borowsky6, Robert D. Cardiff6, Larry S. Barak2,10, Marc G. Caron2,10, H. Kim Lyerly1,7,8,10 &
Joshua C. Snyder 1,2,10*
Field cancerization is a premalignant process marked by clones of oncogenic mutations
spreading through the epithelium. The timescales of intestinal field cancerization can be
variable and the mechanisms driving the rapid spread of oncogenic clones are unknown. Here
we use a Cancer rainbow (Crainbow) modelling system for fluorescently barcoding somatic
mutations and directly visualizing the clonal expansion and spread of oncogenes. Crainbow
shows that mutations of ß-catenin (Ctnnb1) within the intestinal stem cell results in wide-
spread expansion of oncogenes during perinatal development but not in adults. In contrast,
mutations that extrinsically disrupt the stem cell microenvironment can spread in adult
intestine without delay. We observe the rapid spread of premalignant clones in Crainbow
mice expressing oncogenic Rspondin-3 (RSPO3), which occurs by increasing crypt fission and
inhibiting crypt fixation. Crainbow modelling provides insight into how somatic mutations
rapidly spread and a plausible mechanism for predetermining the intratumor heterogeneity
found in colon cancers.
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The process of field cancerization displaces normal cells withfields of premalignant cells harboring mutations to proto-oncogenes and tumor suppressors. Field cancers are
operationally defined by Graham and colleagues as “a group of
cells that are considered to be further along an evolutionary path
toward cancer”1. Fields can present with or without morphologic
pathology. The initiation and spread of field cancers increase
the risk of a tumorigenic event setting the stage for sporadic
cancers1–3. Determining how field cancerization occurs may lead
to new strategies for cancer surveillance and treatment. The
extent of field cancerization in the intestine varies from a few
centimeters adjacent to a tumor or, in other circumstances, can
include nearly the entire colonic epithelium4,5. The current model
of intestinal field cancerization begins with the acquisition of a
somatic mutation in an intestinal stem cell (ISC) within a crypt.
Somatic mutations increase the competitive fitness of the ISC,
resulting in the replacement of neighboring wild-type (WT) ISCs
and the fixation of the mutation in a single crypt6. Premalignant
crypts then duplicate by crypt fission to outcompete and displace
adjacent normal crypts7–9 (Fig. 1a). The entire process is thought
to occur slowly over several decades7,10.
One reason for the proposed slow progression of field cancers
is the paradoxical finding that premalignant ISCs with somatic
mutations, such as KrasG12D, APC-loss, or mutant TP53, can be
stochastically replaced by neighboring WT ISCs. Therefore, field
cancers can be prematurely extinguished by the healthy intes-
tine10. A second reason for the proposed slow progression of field
cancers is that healthy adult intestinal crypts infrequently dupli-
cate—a process termed crypt fission. Less than 2% of crypts are
undergoing fission in adults. Each crypt may only undergo one
fission event every 30–40 years in the healthy intestine9,11.
Therefore, the spread of field cancers is also severely limited.
Crypt fission can be increased by somatic mutations. However, in
familial adenomatous polyposis (FAP) patients and in mouse
models of APC inactivation, the rate of increase is modest and
variable8,9.
Growing evidence suggests that rapid field cancerization can
occur in the intestine as a result of changes to the crypt micro-
environment, epithelial injury, and age. First, perturbations to the
microenvironment can lead to the selective loss of WT ISCs and
their rapid replacement by more fit premalignant ISCs. The
increase in ISC replacement results in the accelerated fixation of
somatic mutations within intestinal crypts and the efficient
initiation of a field cancer12. Second, chronic epithelial injury
induces crypt fission and can spread field cancers throughout the
entire colonic epithelium in less than 4 years4,13. Third, rapid
field cancerization can also occur if somatic mutations are
acquired during intestinal development when more than 20% of
the crypts are actively undergoing crypt fission14,15. However,
somatic mutations that overcome the constraints of intestinal
homeostasis and drive rapid field cancerization in otherwise
healthy adult intestine have still not been found.
Rspondin-3 (RSPO3) is a microenvironmental factor that
regulates ISCs and when overexpressed induces crypt hyperpla-
sia16. Oncogenic fusions of RSPO3 with the protein tyrosine
phosphatase receptor type K (PTPRK) are also known drivers of
colon cancer17,18. RSPO3 and its oncogenic fusions are compel-
ling candidates that could drive the rapid spread of intestinal field
cancers. Current mouse models lack the resolution to easily
investigate the cellular and molecular roles of RSPO3 in field
cancerization. Convenient solutions also do not exist for
expressing and directly comparing multiple RSPO3 mutations
within a single isogenic mouse. Coincidentally, mouse models for
broadly investigating the functional genomics of field canceriza-
tion are also needed. Therefore, we have developed a cancer
rainbow (Crainbow) mouse modelling platform that combines
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Fig. 1 Engineering cancer rainbow mice. a The current two-step model of
intestinal field cancerization. Somatic mutations increase stem cell fitness
and lead to the fixation of premalignant clones within crypts (orange).
Crypt fission results in duplication of premalignant crypts and the lateral
propagation of somatic fields. b The Crainbow expression vector
incorporates 4-tandem cassettes downstream of the ubiquitous chicken-β-
actin promoter (CAG). The construct confers ubiquitous expression of a
membrane-targeted and chemically inducible near-infrared fluorogen-
activating peptide (FAP-Mars1) as a control. Cell type specific activation of
Cre recombinase mediates recombination at one of three positions through
inclusion of three pairs of orthogonal lox sites (LoxN: white triangle,
Lox2272: hatched triangle, and LoxP: filled triangle). Single-copy transgene
insertion provides a single outcome per cell and barcoding of each genetic
fate by fluorescent imaging. c Candidate tumor driver genes are
synthesized/PCR amplified and then In-Fusion® cloned into a bicistronic
expression cassette. Multi-site Gateway™ cloning is used to directionally
clone each pENTR plasmid into a Gateway™-compatible ROSA-targeting
vector in a single step21.
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the desirable features of “Brainbow”19,20 based lineage tracing
with functional genomics screening into one seamless and
interchangeable platform. Crainbow provides a means to induce
multiple somatic mutations and visualize two essential attributes
of field cancerization—ISC competition and clone spreading.
Crainbow modeling directly demonstrates that somatic muta-
tions in the neonatal intestine clonally spread throughout the
intestine during a critical period of intestinal growth and devel-
opment15. In addition, RSPO3 and its fusion isoforms are iden-
tified as a class of oncogenes that extrinsically transforms ISC
behavior resulting in the widespread expansion of oncogenes
throughout the adult epithelium in only a few weeks. Crainbow
modelling is a transformative modelling technology and is a
broadly applicable tool for visualizing the cellular and molecular
dynamics of the early events that drive cancer.
Results
Engineering and validating cancer rainbow mouse models.
Crainbow is a genetic model system for labelling and visualizing
individual cells that express somatic mutations. Included in the
Crainbow transgene are four positions that either express an inert
fluorescent protein (position 0) or three spectrally resolvable
fluorescent proteins paired with an oncogenic mutation of choice
(positions 1–3). In addition, these candidate driver genes are
fused to unique epitopes to ensure that their resultant protein
products can be immunolocalized in tissue. In this manner,
simple activation by Cre recombinase can induce spatiotemporal
expression of fluorescently barcoded tumor driver genes and
single-cell visualization of cell fitness, cell signalling, and the
clonal spread of oncogenic mutations (Fig. 1b). In this report,
several adaptations were made to overcome previous limitations
in construct engineering and imaging21. First, a seamless and
efficient cloning approach for building Crainbow targeting vec-
tors was utilized21–24 (Fig. 1c). Second, the fluorescent protein
(XFP) palette for imaging in vivo and ex vivo was optimized. This
optimization included the use of a chemically inducible near-
infrared fluorescent protein (FAP-Mars121) for mitigating an
overabundant control signal20, targeting XFPs to the nucleus for
cell counting, and delivery of two separate vector systems with
different XFP palettes (Supplementary Figs. 1–3). Third, trans-
gene expression was increased by including the woodchuck
hepatitis posttranscriptional regulatory element (WPRE)25.
Fourth, positional bias inherent to Cre/LoxP systems was
empirically determined in a control mouse. Three Crainbow
mouse models are developed in this study and are summarized in
Table 1.
A Crainbow control mouse was developed to validate transgene
expression and calculate positional bias. The NCAT Crainbow
control mouse model (N-terminally truncated allele of ßcatenin)
encodes the same N-terminally truncated and oncogenic form of
ßcatenin (ΔNßcat) at each position26. Each ΔNßcat is coexpressed
with TagBFP, mTFP1, or mKO (Fig. 2a, Supplementary Fig. 4).
Simple confocal imaging for each fluorescent protein lineage
marker can be used to assess recombination induced positional
bias and the clonal spread of oncogenic mutations. NCAT
Crainbow mice were bred to mice that express Villin-Cre
recombinase to generate NCAT(+/−):VilCre(+/−) mice (NCAT-
VilCre) and thereby induce recombination of Crainbow in the
developing intestinal epithelium (e12.5)27. NCATVilCre mice were
sacrificed between postnatal days (PND) 9–20 and the intestine
was imaged by confocal microscopy. Since TagBFP quenched
after fixation, imaging was performed on freshly isolated tissue
when possible. Wholemount preparations of NCATVilCre intestine
allowed confocal imaging through the serosa and into the
intestinal crypt (Fig. 2b). Intestinal crypts harbor a population of
ISCs that symmetrically divide and stochastically differentiate.
This results in neutral drift behavior of the ISC and crypts that are
populated by a single clone of stem cells—a process also known as
crypt fixation28,29. Confocal imaging of intestinal crypts revealed
that crypt fixation had already occurred in most crypts by the
time of analysis, as evidenced by monoclonal crypts that
expressed TagBFP (cyan), mTFP1 (yellow), or mKO (magenta)
Table 1 Overview of cancer rainbow (Crainbow) mouse lines.
Symbol Name Oncogenea Key observations Map
NCAT N-terminal
truncated ßcatenin
Cre Off:
Mars1 FAP
Cre On:
1. ΔNßcat
2. ΔNßcat
3. ΔNßcat
The positional recombination efficiency of Crainbow is biased 2.3-
fold at position 1, 0.36-fold at position 2, and 0.32-fold at
position 3.
Supplementary Fig. 4,
Supplementary Data 1
MCAT Multiple isoforms
of ßcatenin
Cre Off:
Mars1 FAP
Cre On:
1. ΔNßcat
2. Ccat/Lef1
3. ΔNßcatΔC
Clone expansion occurs rapidly during perinatal development but
is constrained by intestinal epithelial homeostasis in adult.
Supplementary Fig. 5,
Supplementary Data 2
ROBO RSPO3 Crainbow Cre Off:
Mars1 FAP
Cre On:
1. RSPO3
2. PTPRKe1:
RSPO3e2–5
3. PTPRKe1–7:
RSPO3e2–5
RSPO3 oncogenes expand the crypt microenvironment to induce
crypt fission and promote rapid oncogenic clone spreading in the
adult epithelium.
Supplementary Fig. 7,
Supplementary Data 3
aDescription of oncogenes and Crainbow lines. (NCAT) ΔNßcat (aa. 80–781) is based upon the previously described N-terminal truncation mutant and escapes degradation to increase Wnt-signaling26.
NCAT mice express ΔNßcat in positions 1–3 and are used to calculate positional bias in Crainbow transgenes. (MCAT) MCAT mice express three isoforms of ßcat that act as oncogene prototypes.
ΔNßcat was directly compared with ßcat isoforms that possess an increased Wnt-signaling potential (Ccat/Lef1: aa.693-781/aa.57-398)33,34 or a decreased Wnt-signaling potential (ΔNßcatΔC, aa.80-
693)33–35. MCAT mice are used to test the comparative ability of Crainbow modelling and measure oncogenic clone competition of three oncogenes. (ROBO) RSPO3 is expressed by the crypt
microenvironment and controls stem cell homeostasis50. The recently described oncogenic fusions of PTPRKe1:RSPO3e2–5 and PTPRKe1–7:RSPO3e2–5 are known drivers of colorectal cancer16–18. ROBO mice
are used to assess how oncogenic activation of microenvironmental cues could also be potent drivers of the rapid spread of premalignant clones in the adult intestinal epithelium. Oncogenes are
pseudocolored to match the fluorescent protein barcode
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(Fig. 2b, c). Unbiased recombination of Crainbow should result in
a 1/3 chance of activating positions 1, 2, or 3. Therefore, XFP
crypts were counted and normalized to this expected probability
of 0.33 to calculate recombination bias. Values equal to 1 reflect
no bias, whereas >1 are positively biased and <1 are negatively
biased. Crainbow activation has a 2.3-fold positive bias for
position 1 and a concomitant negative bias that was similar for
positions 2 and 3 (Fig. 2d). NCAT mice were also bred to ROSA-
CreER/T2 mice to generate NCAT(+/−):ROSACreER/T2(+/−)
mice (NCATCreER/T2) and treated with tamoxifen to assess
positional bias in adult mice. NCATCreER/T2 were sacrificed
12 days post tamoxifen injection to allow for ISC labelling and
clonal replacement of the differentiated cell lineage. As expected,
stripes of TagBFP, mTFP1, and mKO recombined epithelial cells
emanating from the crypt base were observed by confocal
microscopy of vibratome sliced small intestine (Fig. 2e, f).
Quantification of recombination bias revealed a positive bias for
position 1 and negative bias for positions 2–3. This bias was
similar to the bias observed in developmental NCATVilCre studies
(Fig. 2g). The NCAT studies provided a basis for visualizing the
clonal spreading of oncogenes in the intestine using Crainbow
mouse models.
Intestinal growth accelerates the clonal spread of oncogenes.
Genetic inactivation of adenomatous polyposis coli (APC)
potentiates Wnt signalling and is a known driver of colon can-
cer30–32. ßcatenin is a downstream signaling effector and a prime
candidate for increasing stem cell fitness and initiating field
cancers. Several isoforms of ßcatenin have been used previously
to study Wnt-signaling. ΔNßcat is already described above in
NCAT mice and potentiates Wnt-signaling by escaping degra-
dation. The Ccat/Lef1 isoform is a fusion of the C-terminal
transactivation domain of ßcat to the transcription factor Lef1.
Ccat/Lef1 potentiates Wnt signalling but cannot be sequestered
by epithelial cadherin (CDH1)33,34. ΔNßcatΔC lacks the N-
terminal domain of ßcat and escapes degradation but also lacks
the C-terminal transactivation domain and is thereby unable to
transduce nuclear Wnt signalling33–35. These somatic mutations
vary in their Wnt-signaling aptitude and are excellent prototypes
for validating Crainbow as a robust system that quantifies the
clonal expansion of oncogenes in vivo. Therefore, an MCAT-
Crainbow mouse model (Multiple forms of ßcatenin, Fig. 3a and
Supplementary Figs. 3, 5) was engineered. MCAT also used
mTFP1, EYFP, and mKO palette for more favorable confocal
imaging.
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Fig. 2 Validating Crainbow functionality. a Diagram of NCAT-Crainbowmice. See also Table 1 and Supplementary Fig. 1. b NCATVilCre small intestine (N= 10
mice, PND9–PND20) was prepared as a whole-mount and confocal imaged for XFP expression in the intestinal crypts. c Inset in “b” at higher
magnification. d Crypts were color segmented and counted. The experimentally observed value was normalized to the predicted stochastic outcome (0.33/
XFP). The asterisk denotes statistical significance by one-way ANOVA (TagBFP vs. mTFP1: p < 1e–6, TagBFP vs. mKO: p < 1e–6, mTFP1 vs. mKO: not
significant). NCATCreER/T2 mice (N= 8, 19–22 weeks of age) were injected with 200mg/kg tamoxifen. Mice were sacrificed 12 days post tamoxifen
injection, and the small intestine was vibratome sectioned and antibody stained to recover the quenched TagBFP signal. e Sections were imaged by
confocal microscopy for XFP expression (TagBFP: cyan, EYFP: mTFP1, mKO: magenta; segmented nuclear masks shown and overlaid with surface rendered
tissue outline). f Rotated inset in “e” at higher power. g Nuclei were segmented, counted, and normalized to the predicted stochastic outcome (0.33/XFP).
The asterisk denotes statistical significance by one-way ANOVA (TagBFP vs. mTFP1: p < 1e–6, TagBFP vs. mKO: p < 1e–6, mTFP1 vs. mKO: 8.4e–4). (SEM
included for each graph). Scale Bars= 100 µm in b, c, f and 2mm in e. Source data are provided as a “Source Data file”.
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MCAT Crainbow mice were bred to mice that express Villin-
Cre recombinase to generate MCAT(+/−):VilCre(+/−) mice
(MCATVilCre) and thereby induce recombination of Crainbow in
the developing intestinal epithelium (e12.5)27. Whole-mount
confocal imaging of 3–6-week-old MCATVilCre small intestine
revealed that crypt fixation had already occurred, as was evident
by a single color of epithelial cells in each crypt (Fig. 3b, c). The
spread of oncogenic clones through the intestine was also studied
in MCAT mice. The same ΔNßcat allele was used in Position 1 of
NCAT and MCAT mice. Therefore, a relative clone spreading
potential was calculated by normalizing the MCAT crypt
frequency to the positional recombination bias calculated in
NCATVilCre mice. Ccat/Lef1 expression induced a relative 1.6-fold
increase in clone spreading potential. In contrast, ΔNßCatΔC
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Fig. 3 Widespread expansion of oncogenic clones during perinatal development. a Diagram of MCAT-Crainbow mice. See also Table 1 and Supplementary
Fig. 5. b MCATVilCre small intestine (N= 10 mice, 3–6 weeks of age) prepared as a wholemount and confocal imaged. c Inset in “b” at higher magnification.
d MCATVilCre Crypts were color segmented, counted and normalized to the positional bias calculated in NCATVilCre mice. Asterisk denotes statistical
significance by one-way ANOVA (mTFP1 vs. EYFP: p= 0.003, mTFP1 vs. mKO: p= 0.016, EYFP vs. mKO= 3e–6). e Immunostaining for FLAG, V5, or HA
epitopes (magenta) specific to each ßcat isoform in MCATVilCre small intestine vibratome slices and merged with fluorescent lineage markers (mTFP1:
cyan, EYFP: yellow, and mKO: orange). Arrows denote isoform expression with cognate lineage reporter (FLAG and mTFP1, V5 and EYFP, and HA and
mKO). Corresponding insets depict higher magnification images. Arrowheads denote membrane-localized ßcat, whereas asterisk denotes nuclear-localized
ßcat. Epitope stains (magenta) are also presented as merged and as a single-channel image with its cognate fluorescent lineage reporter (green). f HEK
cells were transiently transfected with MCAT isoforms, fixed, stained, and imaged for the indicated epitope (magenta) and fluorescent reporter (green).
Cells were also cotransfected with epithelial cadherin (CDH1) as indicated. Arrows denote sequestration of ßcat at the plasma membrane, and the asterisk
denotes nuclear ßcat. g Wnt signalling activity for each oncogene in the absence of CDH1 (solid bar) or in the presence of overexpressed CDH1 (hatched
bar) (N= 6 wells per condition and independently repeated in four experiments). TOP FLASH activity was normalized to WNT/RSPO-stimulated control
cells (dashed line). Asterisk denotes statistical significance by two-way ANOVA and Bonferroni’s multiple comparisons test (cyan < 1e–6, yellow= 0.01,
magenta= 0.02). (SEM included for each graph). Scale Bars= 1 mm in b, 100 µm in c/e, 15 µm in e: insets 1–3, and 10 µm in f. Source data are provided as
a “Source Data file”.
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induced a respective 0.4-fold reduction in clone spreading
potential and ΔNßcat was unchanged (Fig. 3d). The proximal to
distal axis of the intestine differs in Wnt/ßcatenin signalling
potential36. ΔNßCatΔC expression resulted in a similar decrease
in clone spreading potential in the colon and the effects of Ccat/
Lef1 were mitigated and more similar to ΔNßcat (Supplementary
Fig. 6a, b).
Epithelial cadherin (CDH1) sequesters ßcat at the lateral
plasma membrane acting as a molecular “sink” for excess ßcat
that ultimately inhibits Wnt-signalling37,38. We hypothesized that
the increased spread of Ccat/Lef1 clones was due to the loss of
CDH1 sequestration activity. Antibody staining for the epitope
tags fused to each ßcat isoform revealed that each isoform was
correctly expressed with its cognate XFP (Fig. 3e, arrows). FLAG
immunostaining for ΔNßcat and HA immunostaining for
ΔNßCatΔC showed plasma membrane sequestration of ßcat with
no detectable nuclear signal (Fig. 3e, arrowheads). In contrast, V5
immunostaining for Ccat/Lef1 revealed nuclear localization with
no detectable expression at the plasma membrane (Fig. 3e,
asterisks). A similar effect was observed in a complementary
in vitro transfection system (Fig. 3f). In addition, a TOP-FLASH
luminescent assay for Wnt signalling39 demonstrated that only
Ccat/Lef1 could effectively transduce Wnt/ßcat signalling in the
presence of CDH1 (Fig. 3g). These results confirmed that
Crainbow modelling could be used for inducing and directly
comparing multiple premalignant epithelial clones harboring
oncogenic mutations and that these clones effectively spread
during perinatal intestinal development.
MCAT mice were also used to study the evolution of oncogenic
clones in adult intestine.MCATmice were bred to ROSA-CreER/T2
mice to generate MCAT(+/−):ROSACreER/T2(+/−) mice
(MCATCreER/T2). Adult MCATCreER/T2 mice were treated with
200mg/kg tamoxifen and chased for 3 days or 8 weeks. Sparse
recombination was observed throughout the villus and crypt
epithelium at day 3 (Fig. 4a). Prior lineage tracing studies of the
intestinal epithelium revealed that recombined villus epithelial
cells are lost within a few days and are replaced by clones of
epithelial cells emanating from recombined ISCs29. Clones of
MCAT recombined cells could be similarly observed 8 weeks after
tamoxifen induced recombination (Fig. 4b). Clones were restricted
to narrow stripes of recombined epithelial cells within each villus
and were typically only a few cells wide. The widespread
recombination of an entire villus was not observed. An estimate
for clone spread was determined by counting the total recombined
cells at day 3 versus 8 weeks. The total number of recombined cells
did not increase from day 3 to 8 weeks for any of the oncogenic
ßcat isoforms. An apparent but statistically insignificant decrease
in total recombined Ccat/Lef1 cells was also observed (Fig. 4c).
Therefore, clone spreading does not significantly occur in adult
MCAT intestine.
The fixation of somatic mutations within a crypt is an initiating
event in cancer field formation. A previous report documented
that ISCs with potent somatic mutations can still be replaced by
neighboring stem cells within the crypt10. Therefore, crypt
fixation rate was measured in MCAT mice. MCATCreER/T2 mice
were treated three times with 200 mg/kg tamoxifen (Days 1, 3,
and 5) to abundantly label multiple ISCs within the crypts. Mice
were sacrificed at Day 7 or at 8 weeks. Whole-mount confocal
imaging of intestinal crypts at day 7 revealed that 42% of crypts
were labelled. Multiple examples of monoclonal, biclonal, or
triclonal crypts were evident (Fig. 4d). Prior lineage tracing
studies demonstrated that crypt fixation occurs within
4–8 weeks29. Whole-mount confocal imaging of MCAT intestinal
crypts 8 weeks after recombination revealed that crypt fixation
had occurred in 15% of the crypts counted (Fig. 4e). The relative
fraction of fixed crypts for each MCAT lineage was calculated at
8 weeks and normalized for positional bias in order to calculate
the relative crypt fixation potential of each ßcat isoform. The
results indicated that the relative fixation potential of mTFP1:
ΔNßcat ISCs was modestly increased compared to the reduced
fixation potential of EYFP:Ccat/Lef1 and mKO:ΔNßCatΔC ISCs
(Fig. 4f). The direct measurement of clone spreading and crypt
fixation within MCAT mice indicates that the normal adult
intestine is resistant to the clonal expansion of oncogenic
mutations.
Interestingly, efficient and widespread field cancerization
during development has previously been attributed to the
plasticity of crypts during development—including crypt fission
and nascent crypt formation14. Intestinal organoid cultures
effectively model crypt plasticity40. Therefore, MCAT organoids
were used as an ex vivo correlate of the clonal expansion of
oncogenes observed during development. ΔNßcat−, Ccat/Lef1−,
ΔNßCatΔC−expressing crypts were isolated from MCATVilCre
mice and similarly established viable organoids in full media
(Fig. 4g, h, Panel 1). MCAT organoids were passaged so that each
lineage could be longitudinally studied for alterations in
competitive fitness over time. Interestingly, CCat/Lef1 expressing
organoids rapidly expanded after multiple rounds of subcultur-
ing, whereas ΔNßcat and ΔNßCatΔC expressing organoids did
not (Fig. 4i and Supplementary Fig. 6c). Paneth cells are the
source of Wnts in organoid culture and are required for organoid
growth41. Organoids were treated with c59 to prevent Wnt
acylation and thereby inhibit Wnt secretion42. Only Ccat/Lef1
expressing organoids grew in the absence of Wnt (Fig. 4g, h, j,
Panel 2). Similarly, organoids require exogenous Rspondins
(RSPO)s for their growth43. Only Ccat/Lef1 organoids could grow
without Rspondin (Fig. 4g, h, j, Panel 3). Ccat/Lef1 organoids
could also grow in the absence of Wnts and RSPO (Fig. 4g, h, j,
Panel 4). Therefore, the oncogenic activation of Wnt/ßcat
signaling endows ISCs with increased fitness that results in their
preferential expansion during a permissive period of intestinal
development but not in healthy adult intestine.
Rapid spreading of oncogenes in the adult intestine by
microenvironmental oncogenesis. The abundant crypt fission
and formation of nascent crypts in organoids is likely due in part
to the artificial reconstitution of the microenvironment, in which
the cells are grown, including important niche factors like (RSPO)
s41,43. RSPO3 is a critical regulator of the intestinal micro-
environment16 and in vivo its expression is normally limited to
the subepithelial mesenchyme of WT intestine (Fig. 5a). RSPO3
fusions with PTPRK have been found in colon cancer patients17
and are protumorigenic in mice18. Therefore, a Crainbow RSPO3
model was generated to test the hypothesis that misexpression of
RSPO3 and its fusion products perturb the microenvironment of
the crypt and induce the spread of oncogenic clones by increasing
crypt fission. ROBO Crainbow mice (RSPO3-Crainbow) encode
RSPO3, PTPRKe1:RSPO3e2–5, and PTPRKe1–7:RSPO3e2–5 at posi-
tions 1–3 of Crainbow and are coexpressed with the mTFP1,
EYFP, and mKO fluorescent protein barcode (Fig. 5b and Sup-
plementary Fig. 7).
ROBO Crainbow mice were bred to mice that express Villin-
Cre recombinase to generate ROBO(+/−):VilCre(+/−) mice
(ROBOVilCre) and thereby induce recombination of Crainbow in
the developing intestinal epithelium (e12.5)27. The resultant
ROBOVilCre pups developed distended abdomens and were
moribund by the time of weaning. Gross anatomical examination
revealed dilated and elongated small and large intestines
compared with WT mice (Fig. 5c). Whole-slide imaging of
H&E stained Swiss-roll WT and ROBOVilCre small and large
intestines revealed an expansion of the crypt zone in the small
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intestine, basal crypt hyperplasia, architectural distortion, and
occasional luminal crypt abscesses (Fig. 5d, Supplementary
Figs. 8–13). Similarly, the colonic crypts were expanded by basal
crypt hyperplasia and architectural distortion including crypt
branching and budding (Fig. 5e, Supplementary Figs. 8–13).
RNA FISH was used to molecularly map the stem cell
compartment in WT and ROBOVilCre intestine. A potent
expansion of the stem cell compartment in ROBOVilCre mice
was observed and included an overabundance of Lgr5-positve
stem cells and Top2a-positive transiently amplifying (TA) cells44
(Fig. 5d, e, Supplementary Figs. 8–13). Conversely, a marked
reduction in differentiated Alpi-positive enterocytes45 was
observed in ROBOVilCre intestine. Reg3b, a recently described
marker of enterocytes adjacent to the stem cell crypt45,46, was
found in scattered cells interposing the TA zone of the crypt and
more mature enterocytes of the villus. Reg3b expressing cells
were also expanded in ROBOVilCre small intestine when
compared with WT. In the colon, Reg3b expressing cells were
less frequent in both WT and ROBOVilCre mice (Fig. 5d, e,
Supplementary Figs. 8–13). ROBOVilCre intestine also had an
expanded proliferative zone and was in contrast to the normal
proliferative zone found in MCATVilCre intestinal crypts (Fig. 5f).
ROBOVilCre organoids also grew in the absence of exogenous
RSPOs (Fig. 5g). These data confirm that ectopic overexpression
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Fig. 4 The crypt microenvironment impairs the spread of oncogenic clones in adults. a, b MCATCreER/T2 mice (>6 weeks of age) were I.P. injected with
200mg/kg of tamoxifen and sacrificed 3 days (N= 8) or 8 weeks later (N= 5). The small intestine was vibratome sectioned and imaged. c Nuclei were
segmented, counted, and normalized to the total volume of tissue imaged. Clone spread was determined by comparing the change in total recombined
nuclei for each fate at day 3 and 8 weeks. Statistical significance by mixed effects modelling and Sidak multicomparison correction (ΔNßcat: p= 0.99,
Ccat/Lef: p= 0.14 ΔNßcatΔC: p= 0.99). d, e MCATCreER/T2 (>6 weeks of age) were injected three times (Day 1, 3, 5) with 200mg/kg tamoxifen and
sacrificed at Day 7 (N= 4) or at 8 weeks (N= 5). The small intestine was whole mount imaged by confocal microscopy. Representative crypts are outlined
and f the relative fraction of crypt fixation events for each ßcat isoform was measured. Statistical significance by one-way ANOVA and Holm-Sidak’s
multiple comparison test (ΔNßcat vs. Ccat/Lef1: p= 0.011 (ΔNßcat vs. ΔNßcatΔC: p= 0.0062, Ccat/Lef1 vs. ΔNßcatΔC p= 0.259). g MCATVilCre crypts
were isolated and cultured as in the indicated media (+/−c59 inhibitor at 10 nM) and then imaged by confocal microscopy. h High-magnification view of
wells (N= 6) from each condition in “g” and rotated corresponding insets. i MCATVilCre organoids were subcultured (P0–P5, and N= 5–10 wells per
subculture) and the entire well imaged by confocal microscopy and organoids of each lineage were counted. Relative clone spreading for each organoid fate
was calculated by normalization to the crypt number (C) at isolation (see also Supplementary Fig. 6c). The asterisk denotes statistical significance by
mixed effects modelling and Dunnett post hoc relative to Crypt control (C) (ΔNßcat: p= 0.03, p= 0.002, p < 0.0001 and Ccat/Lef1: p < 0.0001 for each
asterisk and ΔNßcatΔC p < 0.0001 for each asterisk). j Organoid formation efficiency for MCAT crypts cultured in “g–h.” The asterisk denotes statistical
significance by two-way ANOVA and Tukey’s multiple comparisons test. ENRY conditions: not significant between ßcat isoforms, whereas Ccat/Lef1 was
significantly different from ΔNßcat and ΔNßcatΔC for each treatment (ENRY+ c59: p= 0.0003, ENY: p= 0.03, and ENY+ c59: p= 0.01). (SEM included
for each graph). Scale bars= 200 µm in a, b, 100 µm in d, e, 2 mm in g, and 200 µm in h. Source data are provided as a “Source Data file”.
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Top2a (cyan), Lgr5 (yellow), and Rspo3 (magenta) in paraffin-embedded sections of the small intestine (SI) and colon (Col). b ROBOVilCre mice expressing
oncogenic human RSPO3. Position 0: control and membrane-targeted FAP-Mars1, Position 1: mTFP1 (cyan) coexpressed with 3×FLAG-RSPO3, EYFP (yellow)
coexpressed with V5-PTPRKe1:RSPO3e2–5, and Position 3: mKO (magenta) coexpressed with 3×HA-PTPRKe1–7:RSPO3e2–5 (see also Supplementary Fig. 7).
c Gross examination of the ROBOVilCre mice and gastrointestinal tracts at PND16 compared with WT littermate controls. WT and ROBO d small intestines
(SI) and e colons (Col) were paraffin embedded and sectioned for H&E pathology and coregistry of indicated cell type markers by multiprobe RNA FISH.
Images are insets from whole-slide imaged Swiss rolls (see Supplementary Figs. 8–13). fMCATVilCre and ROBOVilCre mice were injected with EdU (magenta)
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of Rspondins can restructure the microenvironment of the
intestine leading to crypt hyperplasia and the ectopic expansion
of proliferative stem cells throughout the epithelium16,47. We
have termed this process microenvironmental oncogenesis.
Previous reports showed that RSPO3 and RSPO3:PTPRK
fusions are protumorigenic in mice but the lack of lineage tracing
prevented full understanding of how each form of the protein
affects stem cell dynamics18. Therefore, we assessed stem cell
clonality and lineage development in ROBOVilCre small intestine
and compared this to MCATVilCre small intestine. Confocal
imaging revealed that ROBOVilCre intestine was significantly
larger than age-matched MCATVilCre intestine (Fig. 6a). At higher
magnification, MCATVilCre intestine displayed the typical pattern
of single-color clones in the villus that emanate from the base of
the intestinal crypt. In contrast, ROBOVilCre mice had fewer large
single-color clones and instead were characterized by smaller
clones, in which each lineage was heterogeneously mixed
throughout the villus and crypt (Fig. 6b). This suggested that
crypt fixation had been inhibited in ROBOVilCre mice. Whole-
mount confocal imaging crypts revealed that the ROBOVilCre
crypts were markedly polyclonal (Fig. 6c). This was in direct
contrast to the monoclonality and crypt fixation evident in
control MCATVilCre crypts (Fig. 6d). Instances of monoclonality
(Fig. 6e, insets 1–3), biclonality (Fig. 6e, insets 4–6), and
triclonality (Fig. 6e, insets 7, 8) were observed in the ROBOVilCre
crypts. In addition, crypt fission and crypt budding could be
observed in ROBOVilCre crypts by confocal microscopy and
confirmed the histopathology assessment (Fig. 6e, insets 1–3).
Crypt fixation was scored in ROBOVilCre and compared with
MCATVilCre and the control NCATVilCre mice. This analysis
revealed that 95% and 97% of crypts were monoclonal in
MCATVilCre and NCATVilCre mice, respectively. In contrast, only
76% of crypts were monoclonal or fixed in ROBOVilCre mice
(Fig. 6f). Approximately 23% of crypts were biclonal in
ROBOVilCre mice, whereas only 5% and 3% of crypts were
biclonal in MCATVilCre and NCATVilCre mice, respectively.
Triclonal crypts were found in 1% of the ROBOVilCre mice but
were not observed in MCATVilCre or NCATVilCre mice. Crypt
fixation was also inhibited in the colon (Fig. 6g, h). These data
demonstrated that microenvironmental oncogenesis inhibits the
neutral drift behavior of ISCs and attenuates the rate of crypt
fixation.
Next, lineage dynamics and signalling were assessed by single-
cell RNA sequencing (scRNAseq) of crypt enriched tissue isolated
from WT and ROBOVilCre small intestine. t-SNE clustering and
visualization of scRNAseq data revealed ten cell types. Two of
these cell types were fibroblasts and immune cells. The remaining
eight include stem cells, transiently amplifying cells, secretory
Paneth and goblet cells, enteroendocrine cells, and three
populations of enterocytes that could be qualitatively associated
with distinct spatial zones within the villus46 (Fig. 7a, Supple-
mentary Fig. 14). Surprisingly, the overall fractional contribution
of each cell type and the cell-cycle state did not change
significantly betweenWT and ROBO crypts (Fig. 7b, c). Signalling
was also largely unaffected as only 25 genes (23 genes in TA cells
and two genes in ENTb1) were differentially expressed (Supple-
mentary Data 4). The scRNAseq data suggest that microenviron-
mental oncogenesis extrinsically modifies the stem cell
compartment.
Last, we hypothesized that microenvironmental oncogenesis
can promote the expansion of oncogenic clones in adult intestine.
To test this, ROBO mice were bred to ROSA-CreER/T2 mice to
generate ROBO(+/−):ROSACreER/T2(+/−) mice. The resultant
ROBOCreER/T2 mice were injected with a single dose of tamoxifen
and chased for either 3 days or 8 weeks. Both small and large
intestinal mucosa showed crypts with dysplasia of the ISC
compartment at 8 weeks (Supplementary Fig. 15). Confocal
imaging of each lineage demonstrated that there was sporadic
recombination throughout the crypt and villus epithelium at day
3 (Fig. 7d). We found that at 8 weeks recombined cells had spread
throughout the ROBOCreER/T2 intestinal epithelium and were
therefore no longer constrained to a local clone within single
crypts (Fig. 7e). This was in clear contrast to similarly performed
experiments in MCATCreER/T2 mice (Fig. 4a–c). We quantified
clone spreading by counting the total number of recombined cells
at day 3 and 8 weeks. The results indicated oncogenic clones had
significantly spread in ROBOCreER/T2 mice. Specifically, WT
RSPO3 clones increased by 6.7-fold, and PTPRKe1:RSPO3e2–5
clones increased by 1.55-fold whereas PTPRKe1–7:RSPO32–5
clones decreased by 0.55-fold (Fig. 7f). In addition, the resultant
crypts and clones were heterogenous, confirming that neutral
drift and crypt fixation was also impaired in adults (Fig. 7g).
Together, our data illustrate that microenvironmental oncogen-
esis can induce and rapidly spread heterogenous oncogenic clones
in the adult intestine by increasing crypt fission, expanding the
stem cell compartment, and inhibiting crypt fixation.
Discussion
The current study developed a mouse platform useful for mod-
eling the oncogenic and cellular determinants of ISC competition
and the clonal spread of somatic mutations throughout the
intestine. Crainbow mouse models were used to induce somatic
activations and then visualize the evolution and competition of
premalignant epithelial clones by fluorescent imaging. The spa-
tiotemporal activation of somatic mutations was used to identify
the time and microenvironmental constraints present within the
intestine that inhibit the clonal expansion of premalignant epi-
thelium. Crainbow modelling revealed that the microenviron-
ment inherently restricts this process to a susceptible period of
intestinal development. However, in the adult, oncogenic activa-
tion of microenvironmental factors expands the stem cell com-
partment and leads to the rapid spread of oncogenic clones.
Crainbow lineage tracing experiments demonstrated that
oncogenic activation of ßcat (MCAT-Crainbow) results in wide-
spread expansion of premalignant clones during a critical period
of perinatal development but not when activated in adult intestine
(Fig. 8a). This illustrates how early APC inactivation can lead to
increased tumor burden in adults14. The ISC compartment of
mice is established during perinatal growth of the intestine and is
initiated by the nascent formation of intestinal crypts48. The
nascent crypts then multiply throughout the intestine by under-
going several rounds of crypt fission until a mature intestine is
formed, at which time the rate of crypt fission slows15. MCAT
Crainbow studies show that somatic activations can hijack the
normal mechanics of intestinal growth and efficiently spread
premalignant clones before adulthood. The growth of the human
intestine occurs throughout the first 2 years of life and is also
characterized by a sustained increase in crypt fission that mark-
edly attenuates when the intestine reaches maturity11. Therefore,
the infant’s environmental burdens, diet, and injury should be
closely monitored to guard against the spread of oncogenic
clones. Future work should identify additional genetic markers
that could be used as noninvasive measures of premalignant
clones to identify children with increased risk of colon cancer in
adulthood.
The lack of adenomas in ßcat Crainbow mice (NCAT or
MCAT) was surprising—especially since Harada et al.26 have
shown previously that extensive intestinal polyps form when the
N-terminal domain of endogenous ßcatenin is deleted. Our
in vitro signaling assays confirmed ΔNßcat and Ccat/Lef1 iso-
forms were oncogenic as measured by Wnt/Rspondin
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independent TOP-FLASH activity. Interestingly, epithelial cad-
herin expression robustly inhibited the TOP-FLASH activity of
ΔNßcat but not Ccat/Lef1. The in vivo subcellular localization of
ΔNßcat and Ccat/Lef1 confirmed this finding by showing Ccat/
Lef1 was localized to the nucleus whereas ΔNßcat was found at
the lateral adherens junction. These data support the ßcatenin:
Cadherin “sink” model previously proposed37. We conclude that
the overexpression of ßcat in either MCAT or NCAT mice is
unable to overcome the inhibition of Cdh1, further confirming
the importance of Cdh1 as a tumor suppressor38. Additional
complexity may also be due to the compensatory and/or com-
petitive roles of the endogenous ßcat allele in the NCAT/MCAT
Crainbow models.
MCAT organoid experiments provided additional insight into
the spread of oncogenic clones by showing that Ccat/Lef1
expressing organoids outcompete other ßcat isoforms and grow
in the absence of microenvironmental factors. Wnt deprivation
in vivo was similarly shown in a recent study to lead to acceler-
ated crypt fixation rates of pre-malignant ISCs12. Therefore,
selective pressure, like injury or microenvironmental perturba-
tions, could result in an evolutionary bottleneck, the loss of less-fit
ISCs, and the dramatic expansion of a premalignant ISC popu-
lation. The crypt microenvironment also maintains ISC home-
ostasis and is reorganized during crypt morphogenesis41,48.
Therefore, oncogenes that restructure the crypt microenviron-
ment can also spread rapidly in adults. RSPO3 was an obvious
candidate due to its role as a secreted microenvironmental factor
that controls crypt homeostasis and the recent discovery of its
fusions with PTPRK in colon cancer16,17,49. Crainbow lineage
tracing revealed that the oncogenic activation of RSPO3 (ROBO-
Crainbow) expands the stem cell microenvironment. This leads to
rapid spread of oncogenic clones in the adult intestine—a process
we term microenvironmental oncogenesis (Fig. 8b). The altered
crypt microenvironment results in ISC hyperplasia, increased
crypt fission, and a decreased rate of crypt fixation. The reduction
in crypt fixation demonstrates that crypt fixation is not required
for the optimal spread of clones. Importantly, a reduced rate of
crypt fixation also resulted in heterogeneous clones that spread
throughout the intestine. This phenomenon begins to explain the
genetic mechanisms underlying intratumor heterogeneity3.
Crainbow modelling was also used to compare gain-of-
function activity for the PTPRK:RSPO3 fusion isoforms found
in colon cancer17. Endogenous PTPRK is expressed throughout
the intestinal epithelium (Supplementary Fig. 14), whereas the
expression of endogenous RSPO3 is restricted to stromal cells
residing adjacent to the crypt50 (Fig. 5a). The PTPRK:RPSO3
fusion results in juxtaposition of RPSO3 into the open reading
frame of PTPRK and should therefore drive ectopic expression of
RSPO3 and expand the microenvironment. However, each iso-
form may not be functionally equivalent. WT RSPO3 and the
PTPRKe1:RSPO3e2−7 isoform both increased clone spreading
potential, albeit at different rates. We were surprised to find an
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secretory Paneth and Goblet cells, IMMU: immune, ENTEND: enteroendocrine, FIBR: fibroblast). For cell type markers, see also Supplementary Fig. 14.
b Heatmap visualization of cell types present in WT and ROBOVilCre isolates as a percentage of total cells. c Heat map visualization of cell cycle phase as a
percentage of each cell type. d–g ROBOCreER/T2 (N= 9 mice, 6–15 weeks of age) were I.P. injected with 200mg/kg of tamoxifen and sacrificed 3 days (N=
4) or 8 weeks later (N= 5), and the small intestine was vibratome sectioned and imaged by tiling confocal microscopy. Confocal imaged vibratome
sections of ROBOCreER/T2 small intestines at d 3 days or e 8 weeks post tamoxifen injection. f Nuclei were segmented and counted and normalized to the
total volume imaged. Clone spread was determined by comparing the total recombined nuclei for each fate at 8 weeks relative to day 3. The asterisk
denotes statistical significance by mixed effects modelling and Sidak multicomparison correction (RSPO3: <0.000001, PTPRKe1:RSPO3e2–5 (P1:R2-5): p=
0.31 and PTPRKe1–7:RSPO3e2–5 (P1-7:R2-5): p= 0.94). g Evidence for attenuated crypt fixation 8 weeks post tamoxifen injection as revealed by chimeric
crypts in whole-mount confocal imaging. (SEM included for each graph). Scale bars= 100 µm in d, e, g. Source data are provided as a “Source Data file”.
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almost twofold decrease in clone spreading potential for the
PTPRKe1:RSPO3e2−7 isoform. PTPRK is a transmembrane pro-
tein tyrosine phosphatase and through homophilic interactions
on adjacent cells stabilizes cell adhesion and reduces epithelial
invasiveness51. The PTPRKe1–7:RSPO32–5 fusion retains the Ig-
like domain and the fibronectin-III repeat necessary for homo-
philic binding. Therefore, the loss of clone spreading potential
for the PTPRKe1–7:RSPO32–5 fusion could be due to potential
binding with endogenous PTPRK and a reduction in epithelial
invasiveness. RSPO3 is also a secreted protein and may have
autocrine and paracrine effects on adjacent stem cells and the
microenvironment.
In recent work, breast cancer evolution and functional geno-
mics was studied using a compound cross of five mouse lines52.
The inability to resolve multiple mutations within the same tissue
and obligate laborious breeding strategies limit the utility of such
an approach. The major technical benefit of our work is to
directly compare oncogenic mutations in the same model system.
Current models do not easily support such experiments as they
are unwieldy and not appropriately controlled. For instance, the
comparison of multiple transgenic models is not recommended—
transgene variegation, background strain, immunological varia-
tion, and genetic drift are just a few variables confounding the
analysis. Crainbow is a transformative solution to this problem by
enabling in vivo functional genomics at single cell resolution.
Several imaging modalities and experimental workflows are
compatible with Crainbow and together enable the direct visua-
lization of stem cell fitness and premalignant clone competition
within the intestine—together two key attributes of field cancer-
ization. Field cancerization is a defining event of many cancers
that include cancers of the breast, skin, and lung1. Crainbow
modelling is easily adaptable and can be used to visualize
the molecular and cellular attributes of field cancerization in
any organ.
Several decades ago, Hubel and Wiesel demonstrated the
importance of environmentally sensitive critical periods in the
developing brain53. We broaden this paradigm to include critical
periods of development sensitive to the acquisition and propa-
gation of somatic mutations. The oncogenic activation of RSPO3
in adult intestine reactivates the developmental critical period and
facilitates the widespread expansion of premalignant clones. The
accelerated spread of oncogenic clones in the adult intestine
provides a cellular and molecular mechanism for driving the
rapid formation of colon cancers.
Methods
Crainbow mouse engineering. Infusion® (Takara, 638910) and Multisite Gate-
way™ Cloning (Life Technologies, 12537-100) techniques were used to engineer
four customizable Gateway™ pENTR™ plasmids. All cloning steps were followed
from supplier provided protocols. gBlocks® (Integrated DNA Technologies) or
PCR products were used to construct positions 2–4 pENTRs with tripartite nuclear
localization sequences immediately followed by a unique fluorescent protein ter-
minated by a P2A54 cleavage sequence and a WPRE expression enhancing
element25,55. Position one pENTR™ was engineered using a geneblock with Mars:
Sci1 FAP56,57 followed by WPRE. Each gBlock® or PCR product was flanked by
unique attB recombination sites for BP cloning to Gateway pDONR221 vectors
specific to each position 1–4. The individual reactions were transformed to One
Shot® Mach1 Competent cells (ThermoFisher C862003), and minipreps were
Sanger sequenced to validate insert presence and sequence fidelity. Each construct
after BP cloning became a pENTR™ vector with attL sites ready for LR cloning into
any expression or targeting vector that contains the DEST recombination cassette.
All pENTR™ vectors were whole plasmid sequenced at Massachusetts General
Hospital Center for Computational & Integrative Biology DNA Core (https://
dnacore.mgh.harvard.edu/new-cgi-bin/listing.action) and aligned in SnapGene
(GSL Biotech LLC). Each pENTR™ was designed with a multiple cloning site
containing a unique SnaBI restricition site for infusion cloning a gene of interest to
pENTRs 2–4 between the P2A sequence and the WPRE element. Genes were PCR
amplified or synthesized with SnaBI (ThermoFisher FD0404) compatible ends for
Infusion cloning to SnaBI linearized pENTR™ vectors following supplier protocol.
LR Clonase II® (Life Technologies, 11791-100) was used in an overnight reaction
for Multisite Gateway™ Cloning into a ROSA26 mouse targeting vector22,23 that we
previously adapted for Gateway cloning21. Max Efficiency® Stbl2™ competent cells
were transformed (ThermoFisher Scientific 10268-019) and grown at 30 °C to
reduce spontaneous recombination. Minipreps were isolated and restriction
digestion strategies were used to map potentially positive clones. Maxipreps were
grown from these miniprep cultures under the same conditions, and whole plasmid
sequencing was performed. ROSA-Crainbow targeting vectors were linearized by
restriction digestion and then purified by Phenol:Choloroform:Isoamyl Alcohol
(ThermoFisher Scientific 15593031) extraction and Ethanol precipitation. Linear-
ized DNA was resuspended in Tris-EDTA Buffer (1×, Sigma T9285) at 1 ug/uL.
Mouse embryonic stem cell gene targeting and morulae injections were performed
by the Duke Transgenic Mouse facility21.
Mouse husbandry and genotyping. Experiments performed in this study were
conducted in accordance with an approved protocol for the ethical use of animals
in research (Duke Institutional Animal Care and Use Committee protocols: A109-
16-05, A079-16-04, and A034-19-02). Mice were housed in an AALAC certified
specific pathogen free facility and given food and water ad libitum. Crainbow lines
were either genotyped by PCR and by Mars1-SCi1 staining of toes (Supplementary
Fig. 16). In addition to Crainbow lines, the following mouse lines were purchased
from the Jackson Laboratory. ROSA FLPe—Jax-129S4/SvJaeSor-Gt(ROSA)
26Sortm1(FLP1)Dym/J (Stock No: 003946)58, Villin Cre—Jax-B6.Cg-Tg(Vil1-cre)
997Gum/J (Stock No: 004586)27, ROSACreER—JAX-B6;129-Gt(ROSA)26Sortm1
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Fig. 8 Models for the initiation and spread of oncogenic clones. a Early
acquisition of somatic mutations during a critical period drives efficient
spread of oncogenic clones before adulthood. Intestinal development
selects for ISCs with increased fitness. This could bias crypt fixation (i.e.,
neutral drift dynamics) or crypt formation during development.
Premalignant clones can then spread throughout the intestinal epithelium
due to the high rate of crypt fission that is observed in mice (postnatal days
5–22, P5–22)15 and humans (0–2 years of age)11. b Microenvironmental
oncogenesis induces crypt fission and inhibits crypt fixation (i.e., neutral
drift dynamics) in the adult intestine. This results in an expanded stem cell
compartment and the rapid spread of heterogeneous premalignant clones
in the adult intestine.
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(cre/ERT)Nat/J (Stock No: 004847)59. Crainbow models and plasmids are available
from the corresponding author upon reasonable request. Tamoxifen (Sigma,
T5648) was resuspended in corn oil and delivered by intraperitoneal injection at
200 mg/kg.
Mouse organoid culturing. Mouse intestinal enteroids (organoids) were made
according to established protocols60–62. Briefly, mice were sacrificed according to
approved protocol and the entire intestine removed. The small intestine was cut at
the intestine and cecum junction then cut in half to separate the proximal from the
distal small intestine. The upper and proximal half (i.e., duodenum/jejunum) of the
small intestine was flushed with 10–20 ml ice-cold PBS (Genesee 25–507) using a
blunted syringe. The tissue was cut longitudinally and then cut into 2 cm pieces and
washed with ice-cold PBS. Intestinal pieces were in 5 ml ice-cold 5 mM EDTA
(Sigma E6758) while rotating slowly in a cold room for 30 min and then placed on
ice for an additional 30 min. Tissue pieces were moved to a 15 ml tube (Supplier)
containing 5 ml ice cold PBS. The tube was vigorously inverted 20–30 times, the
tissue was collected and then transferred to the next 15 mL tube containing 5 ml
ice-cold PBS. This process was repeated a total of five times. Ten microliters
samples from each tube were assessed on a light microscope to find the fraction
containing the highest density of crypts. The fraction(s) with the most crypts were
filtered through a 70 µm filter (Fisher 22363548) into a BSA (10 mg/mL, Roche
10735086001)-coated conical. Isolated crypts were centrifuged at 400 g for 4 min
and resuspended in ice-cold Matrigel (Corning 356237) at a concentration of 80
crypts/10 µl Matrigel. 10 µl crypt/matrigel suspension was plated per well on a 48
well cell culture plate (Corning 3548) that was prewarmed at 37 °C. The crypt/
matrigel patty was polymerized by moving the plate to a 37 °C incubator for 30 min
and then 200 uL base media (ENRY: EGF, Noggin, Rspondin-1, and Y-27632) was
added per well. Briefly, base ENRY media was made in DMEM/F12 (Gibco 11330-
032) with 1× Antibiotic/Antimycotic (Sigma A5955), 1× N-2 Supplement (Gibco
17502-048), 1× B-27 Supplement (Gibco 12587-010), 50 ng/mL EGF (Peprotech
AF-100-15-100UG), 100 ng/mL Noggin (R&D Systems 1967-NG-025), 500 ng/mL
Rspondin-1 (R&D Systems 4645-RS-025), and 10 uM Y-27632 (Cayman Chemical
10005583). Media was made and stored for up to one at 4 °C and changed every
2–3 days. Weekly subculture was performed by removing growth media, adding
cold Gentle Dissociation Reagent (StemCell Technologies 07174), and pipetting
until matrigel was dissociated from the plastic and then pipetted again until
organoids were broken open to release dead cells from the organoid lumen. Dis-
sociated organoids were centrifuged at 400 g for 4 min to pellet cells and washed
once with ice cold 0.1% BSA in PBS. Organoids were pelleted by centrifugation at
400 g for 4 min and then resuspended in ice-cold matrigel. For experiments using
the PORCN inhibitor Wnt-C59 (Cayman Chemical 16644), a stock solution was
made at 1 mM in DMSO and then diluted to a final 10 nM in ENRY or ENY media.
Multiprobe RNA FISH. Advanced Cell Diagnostics RNAscope® Multiplex Fluor-
escent kit (323100) was used to identify mRNA targets in FFPE tissues sections
from Crainbow mice. We followed the steps outlined in the user manual for FFPE
sample preparation and pretreatment as well as for probe hybridization and signal
development. In addition, we used dyes from the Opal® 7-color Kit (PerkinElmer,
Inc NEL801001KT) for probe labelling as per company specifications. Confocal
imaging was performed as described below. The following probes were used in this
study: Mm-Alpi 436781, Mm-Rspo3 402011, mKO-fp 540071, EYFP-C2 312131-
C2, mTFP1-C3 500271-C3, Mm-Top2a-C4 491221-C4, Mm-Lgr5-C3 312171-C3,
and Mm-Reg3b-C2 478091-C2.
Single-cell RNAseq. We used the BioRad ddSEQTM single-cell isolator (BioRad
12004336) for single cell capture. Briefly, intestinal crypts were isolated according
to standard organoid culturing protocol. Next, isolated crypts were incubated for
approximately 1 h in 0.25% Trypsin (ThermoFisher Scientific 15090046) diluted in
PBS (Genesee Scientific 25–507) with 1 mg/mL Collagenase/Dispase (Sigma
10269638001), 4 uL/mL DNase I solution (ThermoFisher Scientific 90083), and 1
uM Q-VD-OPH (Cayman Chemical 15260) with pipetting every 10 min to further
dissociate cell clumps. Solution was neutralized by adding three volumes of 20%
FBS diluted in PBS with Ca+ and Mg+ (Sigma D8662) and passed through a 20
um mesh filter. Cells were centrifuged 400 g for 4 min and resuspended in 1 mL
0.1% BSA+ 1:250 anticlumping agent (ThermoFisher Scientific 01-0057AE).
Viahance™ (Biopal, Inc CP-50VQ02) reagent was used to remove dead cells and
debris by adding 100 uL to cell suspension and incubating first at room tem-
perature for 5 min then on a magnet for 10 min. The cell suspension was removed
and washed in 10 ml of PBS, centrifuged, and resuspended in 0.1% BSA for
counting using Trypan Blue dye and BioRad TC20™ Automated Cell Counter.
Single cells were brought to a concentration of 3000/µl and libraries generated
using SureCell WTA 3′ Library Prep Kit (Illumina, San Diego, CA) according to
company specification. Sequencing was performed according to company specifi-
cation on an Illumina NextSeq 500 in hi-output mode. Data were preprocessed in
BaseSpace Sequence Hub to build gene matrix files (Illumina, San Diego CA). The
gene matrix files consisting of raw counts at the gene level for each cell which was
analyzed using Rstudio and Seurat(ver.2)63. Briefly, the gene counts for all the cells
in the different conditions were combined into one matrix, normalized, and
adjusted for cell cycle effects. The cell cycle phase for each cell was also determined.
Unsupervised clustering was done to separate out the cell types and markers for the
cell types were identified using differential gene expression. These markers were
then used for identifying the cell subpopulations such as stem cells and enterocytes.
Luminescent signaling assays. Experiments were performed using the HEK 293
STF stable cell line kindly provided by Dr. Jeremy Nathans and described in Xu Q,
et al.39 (PMID 15035989). STF cells were cultured in DMEM (Corning 10-013-CV)
supplemented with 10% FBS (Sigma F2442) and 1% antibiotic/antimycotic (Sigma
A5995) and passaged to a Poly-D-Lysine coated 96 well plate at 75,000 cells per
well. We used 3 ul of Genecellin (Bulldog Bio GC1000) per 1 ug of cDNA for
transfection and added the mixture during cell plating. We used 100 ng/well Renilla
Luciferase (RLuc) cDNA, 10 ng/well ßcatenin Crainbow cDNAs, 90 ng/well E-
cadherin (CDH1, Addgene 45769), and used empty pcDNA3.1+ to equalize total
amount of cDNA across different conditions. The media was changed 24 h after
transfection to MEM (ThermoFisher Scientific 51200-038) supplemented with 10
mM HEPES (ThermoFisher Scientific 15630080) and 1% GlutaMAX (Thermo-
Fisher Scientific 35050061). For stimulation 10% L Cell (ATCC CRL-2648) or L
Cell Wnt-3A (ATCC CRL-2647) conditioned media was added to MEM with or
without R spondin-3 (R&D Systems 3500-RS) to a final concentration of 83.3 ng/
ml. Plates were assayed 24 h later using Luc-Pair™ Duo-Luciferase HS Assay Kit
(GeneCopeia LF005) and read on a DLR compatible luminometer.
ßcatenin in vitro sequestration assays. STF cells were plated on Fibronectin
(Millipore FC010) coated 35 mm glass bottom dishes (MatTek P35G-0-10-C) at
1 × 106 cells per dish and transfected 1 µg of indicated ßcatenin Crainbow plasmid
+/− E-cadherin (CDH1) and 6 µl Genecellin as above. The next day media was
changed to MEM with 10% L cell conditioned media. Cells were fixed at room
temperature for 15 min in 4% PFA, washed once with PBS, and permeabilized/
blocked in FISHX (0.25% Triton-X diluted in 1% Fish Gelatin(Rockland MB-067-
0100)) for 20 min at room temperature. Primary antibodies (Anti-HA: Abcam
ab9111, Anti-V5: ThermoFisher R960-25, and Anti-Flag M2: Sigma F1804) were
diluted in FISHX at 1:500 and incubated at room temperature for 1 h. Samples were
washed 3 times in PBS and incubated with appropriate antibody Alexafluor™-633
(ThermoFisher Goat anti-Chicken A-21103 or anti-Mouse A-21050) diluted 1:1000
FISHX for 1 h at room temperature.
Tissue isolation and histopathology. For whole-mount imaging, tissues were
fixed in 10% NBF overnight. A 1 cm piece of intestine was cut open lengthwise and
placed villus down on a slide with Vectashield mounting medium (Vector
Laboratories Cat. No: H-1000). The slide (VWR Micro Superfrost Plus, Cat. No.
48311-703) had a 22 × 22mm coverslip (VWR micro cover glass, 22 × 22 mm, Cat.
No. 48366-227) taped on both ends so a large coverslip (VWR micro cover glass,
22 × 50 mm, Cat.No. 48393-195) could span over the tissue, compressing it enough
to have a flat imaging plane. NCAT whole-mount imaging was performed on
unfixed and freshly isolated tissue because fixation quenched the TagBFP signal.
For cross-sections (70–100 um) intestine were sectioned on a compresstome® VF-
300-0Z (Precisionary). For histology, tissues were fixed in 10% NBF overnight and
embedded in paraffin at the UC Davis Center for Genomic Pathology Laboratory.
Tissue sections (4 μm) were stained with Mayer’s hematoxylin and eosin (H&E)
and whole slide imaging performed on an AT2 Scanscope (Leica Biosystems, Inc.)
and stored in the Spectrum database (Leica). Images were viewed using Imagescope
software (Leica).
Tissue staining. Antibody staining of vibratome slices was also performed for
TagBFP and epitope tags as described below. For HA and V5 epitope tags, tissues
were permeabilized with FISHX for 1 h, washed, and then blocked with Fc block
(Innovex, NB309-5). Rb-anti-HA (Cell Signaling, Clone C29F4, Cat#3724) or Rb-
anti-V5 (Cell Signaling, Clone D3H8Q, Cat#13202 s) were diluted 1:500 in FISHX
and incubated overnight at 4 °C overnight, washed, and then blocked in FISHX
with 5% Normal Goat Serum (NGS, Thermofisher 1610064) for 30 min. Tissues
were then stained for 1.5 h with Alexa Fluor™-633 goat anti-rabbit (Thermofisher
A21070) diluted 1:500 in FISHX/5%NGS. For FLAG immunostaining, Ms-IgG1-
anti-FLAG (Sigma, F1804) was used at 1:250 and the protocol was similar to HA
and V5 immunostaining but with the inclusion of a mouse-on-mouse blocking
reagent (Jackson Immuno Research Laboratories, AffiniPure Fab Fragment Donkey
Anti-Mouse IgG, 715-007-003) during tissue permeabilization and appropriate
secondary antibody (Alexa Fluor™-633 goat anti-mouse IgG(g1), ThermoFisher
A21126). TagBFP immunostaining was performed similar to HA and V5 staining
but with a cross-reactive GuineaPig (GP) anti-TagRFP antibody (Kerafast
EMU107) diluted 1:500 in FISHX and appropriate secondary antibody (Alexa
Fluor™-633 goat-anti-guinea pig IgG(H+ L), Thermofisher A21105). Stained tissue
sections were mounted with Vectashield mounting medium (Vector Laboratories
Cat. No: H-1000and imaged by confocal microscopy) on glass slides (VWR Micro
Superfrost Plus, Cat. No. 48311-703) and appropriate coverslip (VWR micro cover
glass, 22 × 22 mm, Cat.No. 48366-227) or (VWR micro cover glass, 22 × 50 mm,
Cat.No. 48393-195). For in situ assessment of proliferation mice were I.P. injected
with EdU (Sigma Cat. 900584, 50 mg/kg) 2 h before sacrifice. EdU staining was
performed according to company protocol using a Click-iT™ Plus kit to prevent
quenching of XFPs (Click-iT™ EdU Alexa Fluor™ 647 imaging kit, C10340).
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Confocal microscopy and image analysis. Imaging was performed on a Zeiss
LSM 880 confocal microscope equipped with seven lasers (405, 458, 488, 514, 561,
594, and 633 nm), 34 spectral array detectors (32 GaAsP and two PMTs). All lenses
used Zeiss Plan-Apochromat, and they included 10×/0.45 NA, 20×/0.80 NA, 40×/
1.20 NA Imm Corr, and 63×/1.40 NA Oil DIC. Dichroic beam splitters included:
458/514/561/633. Excitation laser and appropriate detector ranges were used for
multispectral acquisition of XFPs and fluorescent stains. Images were processed
and analyzed with Imaris (Bitplane), FIJI64, and the scikit-image65 Python package.
Imaris was used to view images in 3D, adjust images for figures, and find and count
spots, and in some cases count crypts. FIJI and the scikit-image package were used
to build analysis pipelines for preprocessing data. Briefly, images were first pre-
processed by subtracting channels where necessary to remove noise, followed by
background subtraction, and gaussian or median filtering. Wholemount images
were z-projected into one plane and either segmented by hand (crypt chimerism)
or by thresholding and using a watershed morphological segmentation plugin
(MorphoLibJ, IJBP-plugins66) in FIJI). Nuclei were segmented by intensity
thresholding using the Spot module in IMARIS and organoids (Fig. 3c–e) were
manually counted in IMARIS.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The scRNAseq datasets analyzed in the current study are available at GEO, accession
GSE132402. The source data underlying Figs. 2d, g, 3d, g, 4c, f, i, j, 6f, and 7b are
provided as Source Data file. The data supporting this study are available in the Article,
Supplementary Information, Source Data and available from the authors upon
reasonable request.
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